Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons dr. K. (Kees) Meijer
University Medical Center Groningen

dr. K. (Kees) Meijer

Laboratoriumspecialist Klinische Chemie

Publicaties

Beneficial effect of PTCy and a short duration of immune suppression on relapse risk in acute myeloid leukemia patients with pretransplant MRD

Critical Pitfalls in the Flow Cytometric Analysis of Mast Cells in Patients With Systemic Mastocytosis

Higher helios⁺ treg levels pre- and post-CAR T infusion are associated with inferior outcomes in patients with LBCL

Transformed FL shows improved survival after CAR T-cell therapy compared to de novo LBCL, but early transformation (<12 months) defines a poor-risk subgroup: Results from a nationwide cohort

Improved outcome of allogeneic transplantation in older patients treated for myeloid malignancies using post transplantation cyclophosphamide and reduced duration of immune suppression

Anti-IFC antibodies in a patient with CHAPLE syndrome: Implications for blood management

Newest Fetal Cell Count™ Kit for the detection of fetomaternal hemorrhage shows good clinical performance

CombiFlow: combinatorial AML-specific plasma membrane expression profiles allow longitudinal tracking of clones

Pretransplantation MRD in Older Patients With AML After Treatment With Decitabine or Conventional Chemotherapy

Borrelia burgdorferi mimicking central nervous system relapse in diffuse large B cell lymphoma